Found 7 matching trials
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
PHASE1The body has different ways of fighting infection and disease. No single wa...
Status
Active Not Recruiting
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
PHASE2This is a research study to determine the safety and tolerability of ATLCAR...
Location
Lineberger Comprehensive Cancer Center at University of North Carolina
CD30 CAR for CD30+ NSGCT
PHASE2This is a phase 2 research study that enrolls adult subjects with Nonsemino...
Location
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill
Administration of T Lymphocytes for Prevention of Relapse of Lymphomas
PHASE1The body has different ways of fighting infection and disease. No single wa...
Status
Active Not Recruiting
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
PHASE1Despite the progress in the therapy, Hodgkin's Lymphoma (HL) remains fatal ...
Location
Lineberger Comprehensive Cancer Center
Compassionate Use Re-Infusion of ATLCAR.CD30
N/AThis protocol for compassionate use combines 2 different ways of fighting d...
Status
No Longer Available
Location
Lineberger Comprehensive Cancer Center at University of North Carolina
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
PHASE1The body has different ways of fighting infection and disease. No single wa...
Status
Active Not Recruiting
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill